Multiple Assemblies exist for SMTL entry 5skk
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 10 IN COMPLEX WITH c1(c(cnn1C)NC(c2c(ncc(n2)[C@@H]3COCC3)Nc4cncnc4)=O)C(=O)NC, micromolar IC50=0.011972; X-RAY DIFFRACTION 2.15 Å

SMTL ID
5skk.1
Ligands
ZINC ION; MAGNESIUM ION; N-[1-methyl-5-(methylcarbamoyl)-1H-pyrazol-4-yl]-6-[(3S)-oxolan-3-yl]-3-[(pyrimidin-5-yl)amino]pyrazine-2-carboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5skk.2
Ligands
ZINC ION; MAGNESIUM ION; N-[1-methyl-5-(methylcarbamoyl)-1H-pyrazol-4-yl]-6-[(3S)-oxolan-3-yl]-3-[(pyrimidin-5-yl)amino]pyrazine-2-carboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5skk.3
Ligands
ZINC ION; MAGNESIUM ION; N-[1-methyl-5-(methylcarbamoyl)-1H-pyrazol-4-yl]-6-[(3S)-oxolan-3-yl]-3-[(pyrimidin-5-yl)amino]pyrazine-2-carboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5skk.4
Ligands
ZINC ION; MAGNESIUM ION; N-[1-methyl-5-(methylcarbamoyl)-1H-pyrazol-4-yl]-6-[(3S)-oxolan-3-yl]-3-[(pyrimidin-5-yl)amino]pyrazine-2-carboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer